Scholarly article on 3alpha,21-dihydroxy-5alpha-pregnane-11,20-dione 21-acetate 23930-37-2 from Journal of the American Chemical Society p. 3201,3206

DOI: 10.1021/ja01497a054

Source and publish data:

Journal of the American Chemical Society p. 3201,3206 (1960)

Update date:2022-08-04

Topics:

Authors:

Deghenghi

Engel Engel

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01497a054

Full text of DOI:10.1021/ja01497a054

Products guided by the article

Product name:3alpha,21-dihydroxy-5alpha-pregnane-11,20-dione 21-acetate

Cas No:23930-37-2

R&D Labs maybe for 23930-37-2

NingBO Hong Xiang Biochem.Co.Ltd

website:http://www.hxbiochem.com

Contact:0574-66003444

Address:Ning Bo Bei Lun
SHIFANG SUHONG CHEMICAL CO.,LTD

Contact:+86-838-2224563

Address:Room 1207 Zongchen Sunshine No.128 Taishan South Road,Deyang City,Sichuan China
Changsha Easchem Co.,Limited

website:http://www.easchem.com

Contact:+86-731-89722861 89722891

Address:2/F-4/Bld Colorful Palace, No.605 Changsha Ave, Yuhua Area Changsha Hunan China.
Shanghai Mio Chemical Co., Ltd

Contact:0086 21- 64401188-622

Address:16 Floor NO.2 Jiefang Building, No. 4855 Dushi Road, 201100 Shanghai, P.R.China
Shanghai Science Peptide Biological Technology Co.,ltd

website:http://www.scipeptide.com

Contact:+86-21-51099675

Address:No.8 Changyang Rd

Relevant to this article

Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6- trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5- dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines

Doi:10.1002/(SICI)1521-4184(19996)332:6<201::AID-ARDP201>3.0.CO;2-S
(1999)
Synthesis and structures of salen-supported borates containing siloxides

Doi:10.1021/ic9812003
(1999)
Design and efficient synthesis of novel DNA interstrand cross-linking agents: C2-linked pyrrolo[2,1-c][1,4]benzodiazepine dimers

Doi:10.1055/s-1999-2769
(1999)
Doi:10.1039/jr9510001800
(1951)
Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors

Doi:10.1016/j.bmc.2019.05.013
(2019)
Doi:10.1016/S0040-4039(01)88415-X
(1969)

Article Doi

DOI: 10.1021/ja01497a054